Factors influencing ovulation and the risk of ovarian cancer inBRCA1andBRCA2mutation carriers

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

(2014) Joanne Kotsopoulos et al.   BREAST CANCER RESEARCH AND TREATMENT

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

(2014) Amy P.M. Finch et al.   JOURNAL OF CLINICAL ONCOLOGY

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

(2014) Tara M. Friebel et al.   JNCI-Journal of the National Cancer Institute

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways

(2013) M. A. Merritt et al.   HUMAN REPRODUCTION

Oral Contraceptives and Risk of Ovarian Cancer and Breast Cancer Among High-Risk Women: A Systematic Review and Meta-Analysis

(2013) Patricia G. Moorman et al.   JOURNAL OF CLINICAL ONCOLOGY

Maternal recall of breastfeeding duration twenty years after delivery

(2012) Siv Tone Natland et al.   BMC Medical Research Methodology

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

(2012) N. Mavaddat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations

(2012) SA Narod et al.   CLINICAL GENETICS

Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2

(2012) John R. McLaughlin et al.   JNCI-Journal of the National Cancer Institute

Oral contraceptives and risk of ovarian and breast cancers inBRCAmutation carriers: a meta-analysis

(2011) David Cibula et al.   Expert Review of Anticancer Therapy

The Epidemiology of Endometrial and Ovarian Cancer

(2011) Daniel W. Cramer   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis

(2010) S. Iodice et al.   EUROPEAN JOURNAL OF CANCER

Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype

(2009) M. A. Gates et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass

(2009) Michael H. Roh et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers

(2009) Roger L. Milne et al.   BREAST CANCER RESEARCH AND TREATMENT

Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study

(2009) A. C. Antoniou et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Precursors to pelvic serous carcinoma and their clinical implications

(2009) Ann K. Folkins et al.   GYNECOLOGIC ONCOLOGY

Hormonal Risk Factors for Ovarian Cancer in Premenopausal and Postmenopausal Women

(2008) P. G. Moorman et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective

(2008) E A Jarboe et al.   HISTOPATHOLOGY

Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer Prevention

(2008) Joseph W. Carlson et al.   JOURNAL OF CLINICAL ONCOLOGY

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

(2008) Charles N. Landen et al.   JOURNAL OF CLINICAL ONCOLOGY

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls

(2008)   LANCET